1. Introduction {#sec1}
===============

Access to comprehensive and quality healthcare services is a primary correlate to the overall health and well-being of our nation \[[@bib3],[@bib22]\]. Clinical care emphasizes the positive effects patients receive from medical interventions, while research advances clinical care by directly addressing questions and needs relevant to daily clinical practice \[[@bib8],[@bib17]\]. The Department of Veterans Affairs (VA), which runs the nation\'s largest integrated healthcare system, utilizes clinical research as a key source of comparative evidence on effective clinical treatments that are employed within this health care system \[[@bib29]\].

Successful recruitment into clinical research is a key determinant for timely introduction of novel treatment modalities or more effective therapies in clinical practice \[[@bib7],[@bib16]\]. However, recruitment into these studies often encounters hurdles that prolong the study completion timeline, and therefore impede the progression of advances in care and adoption of research findings \[[@bib21],[@bib32]\]. Travel and time burden on trial participants has been reported to cause significant delays on study execution and completion, although leveraging electronic technologies to address travel burden on participants has been suggested as a feasible solution in clinical research practice \[[@bib4],[@bib10],[@bib11],[@bib25]\].

Technological revolution has provided opportunities for integrating digital resources into clinical research activities \[[@bib1],[@bib24],[@bib26]\]. Some studies have incorporated electronic technologies into research using internet and mobile services for clinical research recruitment and retention, electronic consent processes, internet-based interventions, and for web-based data collection and study result dissemination \[[@bib26]\].

The VA Cooperative Studies Program (CSP) is a clinical research infrastructure embedded within the nation\'s largest integrated healthcare system \[[@bib15]\]. The program, a division of the VA Office of Research and Development (ORD), was established to provide coordination for and enable cooperation on multi-site clinical trials and epidemiological studies that fall within the purview of VA and its infrastructure is comprised of a number of Coordinating Centers that are responsible for the planning and conduct of large multi-site clinical trials in the VA \[[@bib27]\]. CSP also established a consortium of nine VA medical centers (VAMCs) called the Network of Dedicated Enrollment Sites (NODES) that have teams (Nodes) to provide site-level expertise and innovative approaches in addressing challenges to clinical trial execution \[[@bib2],[@bib9],[@bib18],[@bib30]\]. NODES incorporated the Mobile Recruitment (MoRe) unit as a recruitment strategy to expand patient access to clinical research and enhance study enrollment. MoRe utilized digital technology that allowed research teams to meet participants in areas of their preference and convenience, as opposed to putting the onus on participants to travel to the research team to participate in research. This manuscript discusses the use of mobile recruitment as a strategy, which employed mobile technologies to potentially reduce study participant travel and time burden, improve access to clinical research, and thus enhance enrollment for Veterans interested in participating in a VA-sponsored, observational cohort study and mega bio-bank, the "Million Veteran Program (MVP)" \[[@bib13]\].

2. Methods {#sec2}
==========

2.1. MoRe plan development {#sec2.1}
--------------------------

In 2014, the NODES program was tasked with the development of several strategies that would improve study enrollment across CSP\'s portfolio of clinical trials and epidemiologic studies. This effort resulted in the creation of several workgroups, each with a distinct focus on a specific phase of the overall clinical research study cycle. The workgroups examined the current processes in their assigned phases of the study cycle to determine the gaps/weaknesses that served as barriers to study execution and the overall enrollment of participants. One workgroup focused on the development of innovative strategies that would increase access to clinical research for study participants. Mobile Recruitment (MoRe) was proposed as a recruitment strategy for CSP research that would utilize MoRe units as its primary approach to executing that strategy. The MoRe unit utilizes mobile technology for recruitment in a pop-up mobile research recruitment location. This strategy can be used across VA healthcare facilities including the primary or main VA hospital, and their satellite clinics which are called VA Community-Based Outpatient Clinics (CBOCs) \[[@bib14]\]. VA CBOCs were established to increase access to primary and other subspecialty care services for Veterans \[[@bib23]\]. The establishment and utilization of these clinics to improve access to these services has increased over time with 64% of Veterans receiving their care in these locations \[[@bib12],[@bib20]\]. The workgroup\'s efforts centered on creating the MoRe unit and developing standard operating procedures for its use at each Node site (n = 9).

The workgroup identified and selected the Million Veterans Program (MVP), an observational research study, to pilot the MoRe recruitment strategy, based on the following considerations: 1) the study sponsor agreed to the proposal; 2) all Node sites participated as MVP study sites; 3) it was an observational study with simple inclusion criteria (i.e., Veterans using the 10.13039/100000738VA healthcare system for their medical care); and 4) study participants typically completed enrollment in a single visit. It was proposed that the recruitment strategy would be explored for VA clinical trials following the outcome of this pilot.

2.2. Implementation {#sec2.2}
-------------------

CSP purchased and distributed components of the MoRe unit for study recruitment efforts. Each MoRe unit included the components listed in [Table 1](#tbl1){ref-type="table"}, pictured in [Fig. 1](#fig1){ref-type="fig"}, and each site\'s usage of these components varied based on its respective needs. The cost of each MoRe unit with all components was approximately \$2040 in 2014. Utilization of the MoRe unit did not require local institutional approval because most of its components were classified as standard office supplies. The laptops were the only component of the MoRe unit that required local approval from each site\'s Office of Information and Technology (OI&T) because of the need to interface with the VA Networks and Infrastructure Domain. Compliance with the VA\'s Information Security policies, specifically, enhanced data security encryption requirements, ensured the highest level of protection of patient data and sensitive information \[[@bib28]\].Table 1Mobile recruitment (MoRe) unit.Table 1MoRe EquipmentMoRe Blood Draw1. Laptop1. Portable \[Phlebotomy\] Arm Stand2. Laptop Bag2. Phlebotomy Lockable Supply Tote3. Portable printer/copier/scanner3. Portable Privacy Screen4. Collapsible cart4. Insulated Specimen CoolerFig. 1Nodes mobile recruitment (MoRe) unit.Fig. 1

Each Node site developed a process that was conducive to recruitment of participants from either their main VA medical facility or one of their VA CBOCs. It was based on each site\'s respective clinical infrastructure and research operational model. NODES, MVP site teams, and the CSP Coordinating Center submitted an amendment request to the VA Central Institutional Review Board (CIRB) for approval to conduct research activities at the CBOCs that were aligned with each VA medical facility participating as an MVP study site. Since some 10.13039/100000738VA CBOCs are contract facilities i.e. these facilities are not VA-operated clinics but are VA-funded or reimbursed health care facilities that are separate from the main 10.13039/100000738VA medical facility, these sites were not approved by the CIRB to serve as locations for research participant recruitment \[[@bib6]\]. Once the approval to recruit at the VA CBOCs was obtained, meetings were scheduled with CBOC Clinical Managers to discuss the operational logistics of conducting research activities at their clinics before research patient visits were scheduled. These clinical managers were receptive because using MoRe required minimal resources from the CBOC. The MoRe unit enabled study teams to conduct all research activities within an unconventional area in the clinic e.g. conference room, office area, etc. The MoRe unit components provided participant privacy and confidentiality during the recruitment process; the ability to provide printed and signed copies of the informed consent and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) documents to the study participant; supplies to collect and store blood samples; and a mechanism to secure original research documents for authorized transport to the main VA medical facility.

One Node site did not use the MoRe unit at the VA CBOCs as these satellite clinics only provided primary care services to its patients, and these patients visited the main VA medical facility for their specialty care. As a result, the patient pool at the CBOCs was not unique and these patients were approached for the study when they came to the main facility for their specialty care needs. This site used the same procedure for recruitment at their main VA medical facility. The study team at this site leveraged the mobile technology to recruit from different clinics (e.g., specialty clinics, outpatient laboratory, etc.) within the main hospital where recruitment was not otherwise possible due to lack of dedicated research space. Other Node sites used the MoRe unit to recruit in the main medical facility when dedicated space was unavailable, and when not recruiting study participants from the CBOCs.

Once the recruitment strategy was employed, the recruitment data was analyzed prior to and after implementation of the MoRe to determine its impact on study recruitment. It was believed that the recruitment strategy utilizing the MoRe unit could be easily translated to clinical trials within the VA healthcare system if proven effective during its use on the MVP.

3. Results {#sec3}
==========

Node sites implemented the MoRe unit as a recruitment strategy to enroll Veterans into the MVP. Two of the nine Node sites were not included in the outcome analysis as they had previously utilized a similar approach to MoRe, including the use of comparable equipment. These two sites also executed research participant recruitment activities at CBOCs prior to the launch of the recruitment strategy utilizing the MoRe unit. Enrollment outcomes were examined over three-time points during an eighteen-month period at the seven participating sites: pre-intervention, intervention and post-intervention. [Fig. 2](#fig2){ref-type="fig"} demonstrates the number of participants enrolled during the pre-intervention, intervention and post-intervention periods. Across these sites, the intervention period of MoRe integration demonstrated a 36.9% increase in enrollment compared to the previous six months (pre-intervention period). There was a 2% enrollment increase at the six-month post-intervention period as compared to the intervention period. When comparing the pre-intervention period to the post-intervention period (eighteen-months), overall enrollment increased by 38.9% ([Table 2](#tbl2){ref-type="table"}).Fig. 2Total number of participants enrolled.\*All sites (n = 7) collected 18-months of enrollment data, in 6-month intervals.Fig. 2Table 2Mobile Recruitment (MoRe) Unit Effectiveness on Study Enrollment Outcomes.Table 2NODE Site% ImprovementFactors Influencing EnrollmentINTV[a](#tbl2fna){ref-type="table-fn"}Post-INTV[b](#tbl2fnb){ref-type="table-fn"}INTV[a](#tbl2fna){ref-type="table-fn"}Post-INTV[b](#tbl2fnb){ref-type="table-fn"}Site 141.8%28.9%•From end of the Pre-Intervention period (i.e., 6-month prior to Post-INTV^1)^, increased FTE[c](#tbl2fnc){ref-type="table-fn"} with supplemental from 2.0 to 3.0, with 1.0 being unbudgeted support•Initiated MoRe unit in hospital atrium as a frequent location to recruit beyond clinic/lab spaces•Continued with 3.0 FTE[c](#tbl2fnc){ref-type="table-fn"}, which included 1.0 supplemental unbudgeted staff•First MoRe CBOC[e](#tbl2fne){ref-type="table-fn"} activatedSite 273.8%19.8%•Reduction in FTE[c](#tbl2fnc){ref-type="table-fn"} from 2.0 to 1.0 in the 3rd month of the intervention period (vacancy)•Increased FTE[c](#tbl2fnc){ref-type="table-fn"} from 1.0 to 2.0 the 4th month of the intervention period (new hire)•Study was taken off probation in the 4th month (i.e., placed on the 6th month of Pre-INTV[a](#tbl2fna){ref-type="table-fn"} due to low enrollment)•First MoRe CBOC[d](#tbl2fnd){ref-type="table-fn"} activated•Second MoRe CBOC[d](#tbl2fnd){ref-type="table-fn"} activatedSite 3−48.0%−6.5%•Site Investigator transferred to another position•Reduction in FTE[c](#tbl2fnc){ref-type="table-fn"} from 3.5 to 2.0 because staff transferred to another position•Reduction in FTE[c](#tbl2fnc){ref-type="table-fn"} from 2.0 to 1.5 because staff transferred to another positionSite 45.6%0.7%•The site did not report any factors influencing enrollment during this phase.•The site did not report any factors influencing enrollment during this phase.Site 5196.4%−7.7%•From end of the Pre-Intervention period (i.e., 6-month prior to Post-INTV[a](#tbl2fna){ref-type="table-fn"}) increased FTE[c](#tbl2fnc){ref-type="table-fn"} from 1.0 to 2.5 FTE, with 0.5 FTE[c](#tbl2fnc){ref-type="table-fn"} dedicated M-F[e](#tbl2fne){ref-type="table-fn"} to recruit from the lab•Reduction in FTE[c](#tbl2fnc){ref-type="table-fn"} from 2.5 to 1.5 due to Study Coordinator\'s extended leave absenceSite 6−33.4%19.0%•Reduction in FTE[c](#tbl2fnc){ref-type="table-fn"} from 2.0 to 1.0•Unseasonable and severe weather affecting patient travel to study location•First MoRe CBOC[d](#tbl2fnd){ref-type="table-fn"} activated•Increased FTE[c](#tbl2fnc){ref-type="table-fn"} from 1.0 to 2.0 (new hire).•Second MoRe CBOC[d](#tbl2fnd){ref-type="table-fn"} activatedSite 721.8%−40.6%•Execution of Super Recruitment Events and where MoRe was exclusively used, enrollment increased•Increased FTE[c](#tbl2fnc){ref-type="table-fn"} from 2.0 to 3.75, with WOC[f](#tbl2fnf){ref-type="table-fn"} students at 0.75 and NODES staff at 1.0 to support super recruitment events•Lab space available to support study•Logistical barriers with Path/Lab department (i.e., loss of space)•Reduction of FTE[c](#tbl2fnc){ref-type="table-fn"} by 1.5; WOC[f](#tbl2fnf){ref-type="table-fn"} student volunteers went back in school[^2][^3][^4][^5][^6][^7][^8]

4. Discussion {#sec4}
=============

Participant recruitment for clinical research is difficult across various types of institutions and medical conditions. The burden of time and travel on participants has been reported as a common barrier to recruitment \[[@bib4],[@bib5],[@bib11],[@bib19],[@bib31]\]. Although the impact of mobile technology on participant time and travel burden was not directly measured using the MoRe unit, the recruitment outcome utilizing this recruitment strategy is demonstrated in this paper. The MoRe unit expanded MVP recruitment opportunities to 27 additional locations outside the main VA medical facility. MoRe provided flexibility and convenience to the participants by allowing Veterans an opportunity to join MVP without adding extra burden of searching for the research team or location. The MoRe unit offered an intervention that was correlated with improved study participant recruitment in MVP by facilitating research activities in an efficient manner at multiple locations, as opposed to a single, stationary location, that were convenient to the study participants.

The recruitment outcomes of employing the MoRe unit for MVP at seven sites over a period of eighteen months are illustrated in this paper. Five of the seven sites (71%) experienced an increase in enrollment after the initiation of MoRe through the end of the intervention. Four of the seven sites (57%) continued to show an increase from the intervention period through the six-month follow-up period, post intervention ([Fig. 2](#fig2){ref-type="fig"}). The sites that did not demonstrate an increase had other confounding factors that contributed to recruitment disruption ([Table 2](#tbl2){ref-type="table"}) including but not limited to, reduction in staffing support.

Success during the intervention period was not solely attributable to the implementation of MoRe. There was a direct correlation between the increase in research staff and the success of MoRe ([Table 2](#tbl2){ref-type="table"}). To operate MoRe, adequate staffing at each site was essential. Recruitment at the main facility as well as in CBOCs required two or more staff members. The utilization of MoRe, and the number of staff members working on a team, both played a significant role in increasing enrollment in the MVP. While the specific factors (i.e., people or technology) for increased recruitment cannot be differentiated, it highlights that technology is still reliant upon personnel to carry out the strategy. Consequently, budgeting for efforts cannot simply consider equipment/technical requirements. Personnel were essential in deploying the MoRe unit at multiple locations, thereby creating the perfect conditions for participation in MVP. Both components, personnel and technology, enabled a potential reduction in time and travel burden on the participant, the ability to conduct research in an atypical space, and the ability to enhance enrollment by being available in a variety of settings were more important factors than the cost-savings to a study. Each site that had a staffing increase and concurrently implemented the MoRe unit, demonstrated an increase in participant enrollment. When staffing was reduced, the MoRe unit was less likely to be utilized, and subsequently, participant enrollment decreased. Adequate staffing is an important factor for offering recruitment opportunities at multiple locations which can have a direct correlation to participant time/travel burden.

There are several potential limitations related to the design and methodology of this pilot that may impact the generalizability of the results. Not all sites implemented the MoRe unit at the same time or with the same components of the unit. Some sites implemented it at one CBOC location while others utilized it with varying schedules at multiple CBOCs. Staffing gains and losses were not consistent across all sites and these variations were unpredictable, impacting enrollment during different phases of the eighteen-month period. Utilization of the MoRe unit for MVP, which is an observational study with simple inclusion criteria and not a clinical trial, should also be considered as a limitation of this initiative. The participants\' perception on lessening the travel and time burden utilizing this recruitment strategy was not explored in this pilot. Another potential limitation is that while MoRe was unique to NODES, it could be assumed that the research teams' presence in locations not otherwise utilized for research purposes either at the main VA facilities or in CBOCs may have helped to promote the study among the Veterans. Since 2011, MVP has attempted to reach as many Veterans nationwide as possible through targeted advertisements, letters to many Veterans registered at VA facilities, and through multipronged marketing campaigns nationwide, including the participating study sites. The pilot did not assess the frequency or impact of strategies, including increased awareness, employed by study teams or the National Program in relation to utilizing the MoRe units. This could be considered one of its limitations. The applicability of the MoRe unit for recruitment and for other research procedures in clinical trials remains to be examined.

Despite the limitations, the pilot demonstrated several key strengths. It illustrated that recruitment barriers are mitigated using mobile technology if research is conducted at a place of convenience for participants; if research teams extend coverage to more than one location to increase the pool of eligible participants; and if creative strategies and tactics are developed and implemented when local resources are scarce (e.g., space for research is restricted or when the target population is reduced).

Overall, the implementation of the MoRe unit was considered successful in providing Veterans with additional opportunities to participate in MVP by bringing the study to Community Based Outpatient Clinics, where MVP had not previously been offered. Many Veterans prefer CBOCs due to the proximity to their home, reduced traffic, and/or more available parking than at the main VA medical facility. The concept of the MoRe unit is transferrable to any research center and may be applied to a clinical trial within or outside the Department of Veterans Affairs Healthcare System. It is feasible, cost-effective, and an easily available recruitment strategy that can address barriers to successful recruitment of research participants.

Disclaimer {#sec5}
==========

The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the government of the United States.

[^1]: Received approval to join CSP NODES in December 2019.

[^2]: NOTE: Seven of nine Node sites participated in the MoRe intervention evaluation. Initiation of MoRe and time point dates varied by site. All sites (n = 7) collected 18-months of data, in 6-month intervals.

[^3]: INTV = Intervention, the 6-month period when the intervention was completed, and data were collected.

[^4]: Post-INTV = Post-Intervention, the 6-month period of data immediately after the intervention period.

[^5]: FTE = Full-time equivalent (FTE), a unit that indicates the workload of an employed person. E.g., 3.5 = 3 fulltime staff +1 part-time staff.

[^6]: CBOC = Community Based Outpatient Clinic, which became additional study recruitment/enrollment sites within each respective VA Medical Center or Health Care System.

[^7]: M − F = Monday through Friday.

[^8]: WOC = Without compensation employee -- VA Research Administration approved volunteer, unpaid.
